Kimberly D Pringle1,2, Rachel M Burke1,2, Claudia A Steiner3, Umesh D Parashar1, Jacqueline E Tate1. 1. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases. 2. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. Healthcare Cost and Utilization Project, Center for Delivery, Organization, and Markets, Agency for Healthcare Research and Quality, Rockville, Maryland.
Abstract
Background: Rotavirus is a common cause of acute gastroenteritis and has also been associated with generalized tonic-clonic afebrile seizures. Since rotavirus vaccine introduction, hospitalizations for treatment of acute gastroenteritis have decreased. We assess whether there has been an associated decrease in seizure-associated hospitalizations. Methods: We used discharge codes to abstract data on seizure hospitalizations among children <5 years old from the State Inpatient Databases of the Healthcare Cost and Utilization Project. We compared seizure hospitalization rates before and after vaccine introduction, using Poisson regression, stratifying by age and by month and year of admission. We performed a time-series analysis with negative binomial models, constructed using prevaccine data from 2000 to 2006 and controlling for admission month and year. Results: We examined 962899 seizure hospitalizations among children <5 years old during 2000-2013. Seizure rates after vaccine introduction were lower than those before vaccine introduction by 1%-8%, and rate ratios decreased over time. Time-series analyses demonstrated a decrease in the number of seizure-coded hospitalizations in 2012 and 2013, with notable decreases in children 12-17 months and 18-23 months. Conclusions: Our analysis provides evidence for a decrease in seizure hospitalizations following rotavirus vaccine introduction in the United States, with the greatest impact in age groups with a high rotavirus-associated disease burden and during rotavirus infection season. Published by Oxford University Press for the Infectious Diseases Society of America 2018. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Background: Rotavirus is a common cause of acute gastroenteritis and has also been associated with generalized tonic-clonic afebrile seizures. Since rotavirus vaccine introduction, hospitalizations for treatment of acute gastroenteritis have decreased. We assess whether there has been an associated decrease in seizure-associated hospitalizations. Methods: We used discharge codes to abstract data on seizure hospitalizations among children <5 years old from the State Inpatient Databases of the Healthcare Cost and Utilization Project. We compared seizure hospitalization rates before and after vaccine introduction, using Poisson regression, stratifying by age and by month and year of admission. We performed a time-series analysis with negative binomial models, constructed using prevaccine data from 2000 to 2006 and controlling for admission month and year. Results: We examined 962899 seizure hospitalizations among children <5 years old during 2000-2013. Seizure rates after vaccine introduction were lower than those before vaccine introduction by 1%-8%, and rate ratios decreased over time. Time-series analyses demonstrated a decrease in the number of seizure-coded hospitalizations in 2012 and 2013, with notable decreases in children 12-17 months and 18-23 months. Conclusions: Our analysis provides evidence for a decrease in seizure hospitalizations following rotavirus vaccine introduction in the United States, with the greatest impact in age groups with a high rotavirus-associated disease burden and during rotavirus infection season. Published by Oxford University Press for the Infectious Diseases Society of America 2018. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Emily T Martin; Tara Kerin; Dimitri A Christakis; Heidi K Blume; Sidney M Gospe; Jan Vinje; Michael D Bowen; Jon Gentsch; Danielle M Zerr Journal: Pediatrics Date: 2010-11-22 Impact factor: 7.124
Authors: Kimberly Pringle; Cristina V Cardemil; Laura J Pabst; Umesh D Parashar; Margaret M Cortese Journal: Vaccine Date: 2016-11-01 Impact factor: 3.641
Authors: M Lynch; B Lee; P Azimi; J Gentsch; C Glaser; S Gilliam; H G Chang; R Ward; R I Glass Journal: Clin Infect Dis Date: 2001-08-22 Impact factor: 9.079
Authors: Daniel C Payne; James Baggs; Danielle M Zerr; Nicola P Klein; Katherine Yih; Jason Glanz; Aaron T Curns; Eric Weintraub; Umesh D Parashar Journal: Clin Infect Dis Date: 2013-11-20 Impact factor: 9.079
Authors: Veena Hoffman; Remon Abu-Elyazeed; Cheryl Enger; Daina B Esposito; Michael C Doherty; Scott C Quinlan; Kathleen Skerry; Crystal N Holick; Peter Basile; Leonard R Friedland; Nicolas Praet; Stéphanie Wéry; Corinne Willame; David D Dore; Dominique Rosillon Journal: Hum Vaccin Immunother Date: 2018-04-13 Impact factor: 3.452
Authors: Daniel James Hungerford; Neil French; Miren Iturriza-Gómara; Jonathan M Read; Nigel A Cunliffe; Roberto Vivancos Journal: J Epidemiol Community Health Date: 2019-09-11 Impact factor: 3.710
Authors: Paolo Bonanni; Giorgio Conforti; Elisabetta Franco; Giovanni Gabutti; Federico Marchetti; Antonella Mattei; Rosa Prato; Giovanni Vitali Rosati; Francesco Vitale Journal: Hum Vaccin Immunother Date: 2021-08-09 Impact factor: 3.452